1. Growing Demand for Plasma is expected to Drive the Market
Platelets are an important component of blood because they are a critical part of the clotting process. They prevent or stop bleeding and are life-saving therapy for patients, undergoing chemotherapy for cancer treatment, leukemia, bone marrow transplants, organ transplants, and open heart surgery. Chinese patients consumed nearly 300 tons of serum albumin in 2016, which is half of the overall global consumption. About 60 percent of that was imported, and demand is growing at 15% annually. It is the main protein constituent in human plasma. This constantly increasing demand for human plasma will lead to a rapid growth in the apheresis market. Other factors that will drive the market in the future include growing number of platelet donors, improving healthcare infrastructure in emerging economies and reimbursement policies.
2. North America Expected to Lead the Market
North America represented the largest regional market, followed by Europe. While North America will continue to dominate the market during the forecast period, the Asia-Pacific region is expected to register the highest growth. The growth of this regional segment is driven by the improving healthcare infrastructure, significant economic development in emerging markets, and rising focus of key market players in this region.
3. The Centrifugation Technology Segment to Lead the Market
The centrifugation technology segment accounted for the largest share of the global apheresis market in 2015. A large share of this segment can be attributed to the wide applications of centrifugation technology in the separation of plasma and cellular components of the blood. The advantage of this technology includes the low human intervention and easy portability of sample, which is a key factor for the success of this market. Also, a contributing factor is the fact that introduction of a new technique would take a lot of time for acceptance in the industry and require additional education for usage.
4. Leading Companies to Watch
The report also examines the role of the leading market players involved in the industry. Some of the key players listed in the study are:
Asahi Kasei Kuraray Medical Co., Ltd
B. Braun Melsungen AG
Terumo BCT, Inc.
About the Apheresis Market
The apheresis market is expected to grow at a CAGR of about 7.7% during the forecast period. Apheresis is primarily accepted as an acute therapeutic method in a variety of diseases, and millions of patients undergo the treatment every year. Today, it is considered, as a treatment option for a large number of chronic diseases, such as rheumatoid arthritis, cancer, and multiple sclerosis among others. The global blood plasma market is highly competitive consisting of several large conglomerates such as Baxter international.
Mordor Intelligence is a market intelligence and advisory firm operating in 14 industry segments, serving over 600 clients worldwide.